About This Video
NeonMind Biosciences Inc. is a newly listed public company on the Canadian Securities Exchange stock market under the symbol NEON.
The Issuer is conducting research into potentially therapeutic uses of compounds found in psychedelic mushrooms and is commercializing edible mushroom infused beverages.
For more information on NeonMind Biosciences head to: https://thecse.com/en/listings/life-sciences/neonmind-biosciences-inc
Subscribe for more great CSE insights and interviews here: https://bit.ly/CSETVSubscribe
STAY CONNECTED WITH THE CSE
=============================
- PODCAST: https://blog.thecse.com/pe-podcasts/
- INSTAGRAM: https://www.instagram.com/canadianexchange/
- LINKEDIN: https://ca.linkedin.com/company/canadian-securities-exchange
- FACEBOOK: https://www.facebook.com/CanadianSecuritiesExchange/
- TWITTER: https://twitter.com/CSE_News
- BLOG: https://blog.thecse.com/
- WEBSITE: https://thecse.com/
Read the TranscriptAuto-generated by YouTube; names and terms may be misspelled.
thanks for tuning in to another newly listed on the csc clip and today i'm joined by rob tessarolo rob is a newly appointed ceo of neon mine biosciences the company listed late in december so rob thank you so much for joining us today how are you i'm great and neil thanks for having me on on your show yeah of course you know you've you've just very recently joined the company
why don't you tell us a little bit about yourself okay yes as you mentioned i joined neon biosciences just earlier this week as president and ceo i've spent about 25 years in pharmaceuticals across multiple roles leading startups as well as larger companies through operational execution and various scaling activities i have extensive experience commercializing new products in small mid and large companies i've worked in the us and canadian
marketplaces and importantly for this assignment or this opportunity i've got commercial business development experience with obesity addiction and other neurological assets i also you know i like transactions i've got lots of experience doing pharmaceutical deal transactions asset licensing r d collaborations and acquisitions of products and lots of companies great thanks for that introduction there but why don't you tell us a little bit about neon mind biosciences what do you guys
do and what's the vision yeah thanks so neon mind biosciences is a psychedelic drug development company and we're focused on conducting research into the potential therapeutic uses of psychedelic substances we believe we're just scratching the surface of the potential for psychedelics to heal and we think these treatments may help solve lots of frankly lots of humanity's biggest challenges including addiction depression ptsd and obesity as a company we've decided our first
step is tackling one of the biggest health issues that the world faces in obesity i mean it's an epidemic and it's responsible for nearly 37 percent of the total global burden of disease conducting a pre-clinical trial currently at the university of british columbia examining psilocybin as a treatment for weight loss and we're designing what we believe will be the world's first phase two human clinical trial using
psilocybin to cause weight loss got it you know obviously there's a lot of buzz around this this psychedelic sector why did you guys choose to go public yeah it's an important question and lots of private companies get asked that question when they're thinking about tapping into the public markets and for us it really comes down to two main reasons first you know it provides liquidity to our current and our future investors
which we hope will be plentiful but moreover as a public entity our neon mind can access the capital that's necessary to advance the development of these new psychedelic medicines despite the surging interest in the psychedelic industry these are indeed your early days with exciting opportunities and as we've seen over and over again when you combine an emerging and emerging industry with the capital markets it drives a lot of investor attention
capital flows and you know you can afford to to invest in a lot of innovative ideas and eventually you know you can have normal discoveries and investors will be rewarded you know ultimately for us neon mine we're hopeful that this results in patients getting access to novel psychedelic treatments for their conditions this is where we're at as a company and we think we think the industry has enormous
potential and we're really this is really early in the effort rob can you can you talk to our audience about maybe a couple of key factors that differentiates a company like neon mine biosciences from some of the others in this space yeah so neon mind has established you know a very unreal position with our unique intellectual property portfolio portfolio and our distinctive focus on obesity our our focus on using psilocybin as a
treatment for obesity is quite novel as i've mentioned it's a significant problem in both the developed and developing world and you know sadly more than there are close to three million people die annually from from from being obese or overweight and the problem is getting is just getting worse we know scientifically that psilocybin activates serotonin receptors and serotonin can cure curve cravings shut off appetite and reduce eating
on the intellectual property front we have several patents pending that cover the administration of psychedelic compounds to aid in weight loss food cravings and treat obesity and complications of compulsive food disorders and we think that it's tremendously important in this industry to have the ability to protect our interventions which will be key to value creation you know over time as the psychedelic industry evolves rob were you able to talk to us a little
bit about some of your key team members yeah right so so as we've already mentioned i've recently joined neon mind after being introduced to you know the company's dynamic founder penny white who was a former ceo so penny is a serial entrepreneur with over two decades of experience building companies under her leadership neon mind was successful in identifying novel areas for psychedelic research and pursued patent
applications to protect the intellectual properties associated with these discoveries and as i've gotten to know the board which she's now the executive chairman of i've found it to be a small group a strong strong director independence of course but with a cohesive view of supporting an entrepreneurial company in a fast-paced growing sector i think importantly for us in drug development we have an impressive clinical development team for our early research we partnered with
medical team at translational life sciences whose work was impressive and we've expanded our collaboration with them and we've taken an ownership stake in tls dr will paninka who's the founder of tl tls is he's a dually certified neurologist and psychiatrist and a canadian institute of health research funded academic faculty member at the university of british columbia dr pineka did his post-doctoral at ubc and in harvard and he maintains an
internationally renowned and recognized program in brain injury mental health and addiction so so will's been tremendously important to our company in terms of helping us direct where our research is going and what opportunities there are for us we recently appointed dr larry birmingham to the neon mines board of advisors okay dr birmingham is an internal medicine specialist an epidemiologist and biostatistician with you know extensive experience and
design of clinical trials that are associated with eating disorders and he's pioneered several internationally recognized treatments he's been at it for over 30 years he's well published and he's actually leading to the design of our phase two trial for psilocybin and obesity which we think is quite exciting on the management's team side trevor millar has been recently appointed as the chief psychedelic officer trevor is a social
entrepreneur who's played a key role in advancing the psychedelic movement over the last eight years he currently serves on the board of maps canada the multi-disciplinary association for psychedelic studies where he's been the chair for the last two years as well he was he's an active member and he's the founding one of the founders of the canadian psychedelic association and he's importantly he's a former
executive director of the globe the global ibogaine therapy alliance so he's got just a tremendous amount of experience in this milieu working with these substances thanks for giving our audience a little bit of information on some of your key team members are there any milestones our viewers can look out for in the coming weeks and months yeah sure neil we're quite excited about what 2021 and the prospect of 2021
holds for for me online biosciences you know over the course of 2021 we look forward to announcing the results of our pre-clinical trial we we hope to initiate do we expect to initiate a phase two psilocybin trial and obesity and with this the sector you know rapidly expanding and just ever busy we will continue to be very active in corporate development and we expect to
bolster our intellectual property position and source additional novel and intriguing you know concepts for psychedelic development programs for our company got it rob where can our viewers go to keep up with your company what's your website and social media great yeah so we're very active on social media and and we can largely be found through our website at neonmind.com and so you can follow us
there and use that call sign to see us on a variety of social media interfaces perfect rob welcome again on board to the company us at the csc are looking forward to watching your company succeed and grow to our viewers if you like content like this and and like to learn about newly listed companies please feel free to subscribe and share this content this has been rob tessarolo who is the
newly appointed president and ceo of neon mind biosciences rob thank you so much for your time and you have a great day thanks so much i appreciate you having me here thank you for tuning in to another newly listed on the csc please feel free to hit like and share this content and hit subscribe if you haven't already



